Fundraising Fox
Vincent Miles
InvestorPartner at Abingworth
Boston, Massachusetts
Writes $15M – $30M checks · typically $22.5M
Find your path to Vincent
Sign up to see every warm intro you have to Vincent
- Paths you didn't know you had: your email and LinkedIn already hold routes to Vincent. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Vincent Miles is an Executive Director at Abingworth, which he joined in 2007, where he helps identify and evaluate new business opportunities and supports portfolio companies. He previously served as Senior Vice President of Business Development at Alnylam Pharmaceuticals and held VP roles at Millennium Pharmaceuticals, and earlier led the technology transfer office at the Dana-Farber Cancer Institute and held positions at RiboGene, Pharmacia, and Amersham International. He holds a BSc in Biochemistry and a PhD in Biochemical Embryology from University College London.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Board seats
Atsena TherapeuticsBrave BioChiasmaDicerna PharmaceuticalsDynex TechnologiesHydra BiosciencesIFM DueIFM TherapeuticsIFM TreMagellan DiagnosticsNido BiosciencesPersonalisPrimeraDx
Investor
ChiasmaHydra BiosciencesPrimeraDx (Primera Biosystems)
Sources: the firm's website · curated public sources.
Colleagues at Abingworth
Frequently asked questions
- Who is Vincent Miles?
- Vincent Miles is an Executive Director at Abingworth, which he joined in 2007, where he helps identify and evaluate new business opportunities and supports portfolio companies. He previously served as Senior Vice President of Business Development at Alnylam Pharmaceuticals and held VP roles at Millennium Pharmaceuticals, and earlier led the technology transfer office at the Dana-Farber Cancer Institute and held positions at RiboGene, Pharmacia, and Amersham International. He holds a BSc in Biochemistry and a PhD in Biochemical Embryology from University College London.
- Where does Vincent Miles work?
- Vincent Miles is Partner at Abingworth.
- What does Vincent Miles invest in?
- Vincent Miles invests in Biotech.
- What check size does Vincent Miles write?
- Vincent Miles typically writes checks of $15M – $30M.
- What boards does Vincent Miles sit on?
- Vincent Miles holds tracked board seats at Atsena Therapeutics, Brave Bio, Chiasma, Dicerna Pharmaceuticals, Dynex Technologies, Hydra Biosciences, IFM Due, IFM Therapeutics, IFM Tre, Magellan Diagnostics.
- What companies has Vincent Miles invested in?
- Investments tracked here include Chiasma, Hydra Biosciences, PrimeraDx (Primera Biosystems).
About this profile. Compiled from public sources — Abingworth's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights